Search

Search Constraints

You searched for: Author/Creator Wingerchuk, Dean M

Search Results

1. Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders. (November 2018)

4. Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension. (March 2022)

5. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. Issue 1 (January 2016)

6. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis. Issue 4 (21st July 2018)

7. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. Issue 10206 (12th October 2019)

9. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders. Issue 3 (2nd December 2016)